These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14565615)

  • 21. Improvement of HAART in Brazil, 1998-2008: a nationwide assessment of survival times after AIDS diagnosis among men who have sex with men.
    Malta M; da Silva CM; Magnanini MM; Wirtz AL; Perissé AR; Beyrer C; Strathdee SA; Bastos FI
    BMC Public Health; 2015 Mar; 15():226. PubMed ID: 25886530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treating AIDS: dilemmas of unequal access in Uganda.
    Whyte SR; Whyte MA; Meinert L; Kyaddondo B
    SAHARA J; 2004 May; 1(1):14-26. PubMed ID: 17600996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.
    Etard JF; Ndiaye I; Thierry-Mieg M; Guèye NF; Guèye PM; Lanièce I; Dieng AB; Diouf A; Laurent C; Mboup S; Sow PS; Delaporte E
    AIDS; 2006 May; 20(8):1181-9. PubMed ID: 16691070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Approaches to rationing antiretroviral treatment: ethical and equity implications.
    Bennett S; Chanfreau C
    Bull World Health Organ; 2005 Jul; 83(7):541-7. PubMed ID: 16175829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiretroviral manufacturers and the challenge of universal access to drugs through the Brazilian National STD/AIDS Program.
    do Lago RF; Costa Ndo R
    Cad Saude Publica; 2009 Oct; 25(10):2273-84. PubMed ID: 19851626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The evaluation of the HIV/AIDS drug access initiatives in Côte d'Ivoire, Senegal and Uganda: how access to antiretroviral treatment can become feasible in Africa.
    Katzenstein D; Laga M; Moatti JP
    AIDS; 2003 Jul; 17 Suppl 3():S1-4. PubMed ID: 14565603
    [No Abstract]   [Full Text] [Related]  

  • 27. [AIDS treatment in Africa: the risk of antiretroviral resistance].
    Hamers RL; Schuurman R; van Vugt M; Derdelinckx I; Rinke de Wit TF
    Ned Tijdschr Geneeskd; 2007 Dec; 151(48):2666-71. PubMed ID: 18179083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The economics of effective AIDS treatment in Thailand.
    Over M; Revenga A; Masaki E; Peerapatanapokin W; Gold J; Tangcharoensathien V; Thanprasertsuk S
    AIDS; 2007 Jul; 21 Suppl 4():S105-16. PubMed ID: 17620745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment in developing countries: new UNAIDS pilot program.
    James JS
    AIDS Treat News; 1997 Nov; (No 283):7. PubMed ID: 11364911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance.
    Weidle PJ; Malamba S; Mwebaze R; Sozi C; Rukundo G; Downing R; Hanson D; Ochola D; Mugyenyi P; Mermin J; Samb B; Lackritz E
    Lancet; 2002 Jul; 360(9326):34-40. PubMed ID: 12114039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand's National Access to Antiretroviral Program.
    Puthanakit T; Oberdorfer A; Akarathum N; Kanjanavanit S; Wannarit P; Sirisanthana T; Sirisanthana V
    Clin Infect Dis; 2005 Jul; 41(1):100-7. PubMed ID: 15937769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Basing treatment on rights rather than ability to pay: 3 by 5.
    Mukherjee J
    Lancet; 2004 Mar; 363(9414):1071-2. PubMed ID: 15065564
    [No Abstract]   [Full Text] [Related]  

  • 33. Out of Africa: Uganda and UNAIDS advance a bold experiment.
    Zuniga J
    J Int Assoc Physicians AIDS Care; 1999 Oct; 5(10):48-60. PubMed ID: 11366872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The affordability of antiretroviral therapy in developing countries: what policymakers need to know.
    Forsythe SS
    AIDS; 1998; 12 Suppl 2():S11-8. PubMed ID: 9792357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Access to treatment for HIV/AIDS: a human rights issue in the developing world.
    Joni J
    Conn J Int Law; 2002; 17(2):273-80. PubMed ID: 12688296
    [No Abstract]   [Full Text] [Related]  

  • 36. Costs of medical services for patients with HIV/AIDS in Khon Kaen, Thailand.
    Kitajima T; Kobayashi Y; Chaipah W; Sato H; Chadbunchachai W; Thuennadee R
    AIDS; 2003 Nov; 17(16):2375-81. PubMed ID: 14571190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The (political) economics of antiretroviral treatment in developing countries.
    Nattrass NJ
    Trends Microbiol; 2008 Dec; 16(12):574-9. PubMed ID: 18964022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production of antiretroviral drugs in middle- and low-income countries.
    Pinheiro Edos S; Brüning K; Macedo MF; Siani AC
    Antivir Ther; 2014; 19 Suppl 3():49-55. PubMed ID: 25310755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preventing HIV transmission in "priority" countries.
    Finger WR
    Netw Res Triangle Park N C; 1993 May; 13(4):18-21. PubMed ID: 12344871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.